Citigroup’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.78M Sell
82,906
-20,000
-19% -$1.15M ﹤0.01% 1446
2025
Q1
$6M Buy
102,906
+60,009
+140% +$3.5M ﹤0.01% 1267
2024
Q4
$3.45M Buy
42,897
+6,821
+19% +$549K ﹤0.01% 1717
2024
Q3
$2.89M Buy
36,076
+22,483
+165% +$1.8M ﹤0.01% 1759
2024
Q2
$830K Buy
13,593
+2,750
+25% +$168K ﹤0.01% 2378
2024
Q1
$536K Buy
10,843
+972
+10% +$48K ﹤0.01% 2805
2023
Q4
$414K Buy
9,871
+3,954
+67% +$166K ﹤0.01% 2823
2023
Q3
$194K Sell
5,917
-14,773
-71% -$485K ﹤0.01% 2993
2023
Q2
$731K Buy
20,690
+13,793
+200% +$488K ﹤0.01% 2466
2023
Q1
$196K Buy
6,897
+1,644
+31% +$46.7K ﹤0.01% 3136
2022
Q4
$218K Sell
5,253
-1,533
-23% -$63.7K ﹤0.01% 2993
2022
Q3
$281K Buy
6,786
+3,500
+107% +$145K ﹤0.01% 2915
2022
Q2
$107K Buy
3,286
+2,929
+820% +$95.4K ﹤0.01% 3521
2022
Q1
$12K Sell
357
-1,563
-81% -$52.5K ﹤0.01% 4659
2021
Q4
$48K Buy
+1,920
New +$48K ﹤0.01% 4319